Aviv Clinics Spotlights New Study Sharing Further Evidence That Specific Hyperbaric Oxygen Therapy is Effective in Fighting Aging
July 09 2024 - 8:00AM
Aviv Clinics, one of the most advanced brain clinics in the world,
shares the results of a new study showing a unique hyperbaric
oxygen therapy (HBOT) protocol is effective for enhancing physical
performance in aging adults.
The study, Physical enhancement of older adults
using hyperbaric oxygen: a randomized controlled trial, was
conducted by Sagol Center for Hyperbaric Medicine and Research at
the Shamir Medical Center and Tel Aviv University, and published in
the BioMed Central journal Geriatrics.
The study evaluated the effect of HBOT on
non-pathological and aging adults’ physical performance and cardiac
perfusion, the measure of how blood flows to the heart muscle. In
this randomized controlled trial, 63 patients 65 years old and
older were randomized to one of the two study arms—the control
group and the HBOT treatment group. The HBOT group received 60
daily HBOT sessions using a specific protocol. Participants’
cardiopulmonary exercise test (CPET) including VO2Max, the maximal
oxygen consumption capacity, anaerobic threshold (the exertion
level between aerobic and anaerobic performance) and maximal power
generation were evaluated. In addition, cardiac perfusion was
evaluated through novel cardiac MRI.
Results showed that following the HBOT protocol,
participants’ VO2Max, VO2Max per body weight, maximal power and the
anaerobic threshold significantly improved. When compared to the
control group, the HBOT group also saw notable increases in cardiac
blood flow and cardiac blood volume.
“Following our first two studies related to how
HBOT can fight cognitive age-related decline and reverse aging at
the cellular level, this study related to physical enhancement is
further evidence that HBOT is effective in alternating the aging
trajectory,” said Dr. Amir Hadanny, Chief Medical Officer and Head
of Research at Aviv Scientific and the principle investigator of
the study at the Sagol Center. “The correlation between physical
performance improvement and cardiac perfusion increase suggests the
mechanism of action. We utilized the same HBOT protocol that
improved cognitive function, to elevate physical performance. With
this, we have the potential to change the trajectory of the normal
aging process.”
HBOT is a medical treatment in which 100% oxygen
is administered at an increased environmental pressure. Aviv’s
unique HBOT protocol, the hyperoxic-hypoxic paradox, fluctuates
oxygen levels along the treatment and was proved to repair and
regenerate damaged brain tissue in several types of brain injuries
including traumatic brain injury, stroke, PTSD, long COVID and
age-related cognitive decline, among others. Previous studies from
the research team at the Sagol Center for Hyperbaric Medicine and
Research have demonstrated the efficacy of HBOT for cognitive
enhancement of older adults and for increasing telomere length
and decreasing immunosenescence in isolated blood cells.
Aviv Clinics offers an advanced treatment
program with a multidisciplinary team of medical experts providing
patients with top-line care and the opportunity to improve their
quality of life. The Aviv Medical Program includes an in-depth
assessment of the patient’s physical and neurological condition to
assess the fit for the program. For patients that meet the
criteria, the Aviv team will then prepare a comprehensive treatment
schedule combining HBOT with personal cognitive and physical
training, and dietary coaching, for a holistic approach to patient
health. The HBOT sessions are conducted in state-of-the-art
multiplace chambers that are comfortable, safe and allow for
medical staff to accompany patients during the treatment. The
elevated pressure in the HBOT chamber creates an optimal
oxygenation condition, ultimately encouraging damaged brain and
body tissues to regenerate and heal.
The full study is available here. For more on
Aviv Clinics, visit aviv-clinics.com.
About Aviv ClinicsAviv Clinics
is the leader in the research and treatment of age-related
cognitive and functional decline and novel applications of
hyperbaric oxygen therapy (HBOT) to maximize human performance.
Based on an exclusive partnership with the world’s largest
hyperbaric medicine and research facility, the Sagol Center at
Shamir Medical Center in Israel, Aviv is introducing a global
network of clinics delivering the most effective evidence-based
treatment of the aging related decline—the Aviv
Medical Program. The three-month regimen was developed based on
over a decade of research and thousands of patients treated
worldwide under the scientific leadership of Shai Efrati, M.D.,
chair of Aviv Scientific’s Medical Advisory Board and director of
the Sagol Center.
Media ContactHannah WilliamsUproar PR for Aviv
Clinicshwilliams@uproarpr.com